Non-treatment innovations aimed at improving cancer outcomes in the developing world are invited to apply to Astellas Oncology’s flagship cancer care award.
The C3 (Changing Cancer Care) Prize is back, and this year it will champion projects in cancer care in the developing world, which bears a disproportionate burden of the global cancer epidemic – around 70% of global cancer deaths occur in low- and middle-income countries.1
Mark Reisenauer, senior vice president of the oncology business unit at Astellas, said: “Given the increasing cancer rates in low- and middle-income countries, and the limited tools and resources available in these regions, this year’s C3 Prize is focused on discovering innovative approaches to help narrow the global disparity in cancer care.”
“Since the initial launch of the Astellas Oncology C3 Prize, we have seen a tremendous response and we wanted to focus this momentum to regions of the world with the greatest need.”
Launched in 2016, the C3 Prize was inspired by Mark’s experience of the patient journey when he lost his father to head and neck cancer.
It aims to shine a light on non-treatment ideas and projects that could improve cancer care in areas such as adherence to treatment, pathway navigation, coordination and survivorship.
“Despite significant advances in treatment, patients and caregivers still face obstacles to receiving or providing optimal care. While development of innovative treatments is critical, education, support and commitment to community are essential parts of the cancer care continuum,” he said in a blog.
Since its creation, the program has supported eight projects to the tune of $200,000 in grant funding.
Last year’s Grand Prize winner, Hernâni Oliveira’s HOPE project, is a two-part game and app for pediatric cancer patients and their parents. As well as age-appropriate disease and management education, the project aims to keep children and young people physically active as they undergo treatment.
In 2016, Oncomfort, a virtual reality tool that delivers psychological interventions including cognitive behavioral therapy, exposure therapy, acceptance therapy and mindfulness scooped the top prize.
This year, patients, caregivers, healthcare professionals and anyone else who wants to improve cancer care is invited to submit ideas that address specific challenges encountered in low- and middle-income countries.
The three categories are support tools, educational tools and technology, and the winners from each will present their ideas to a live panel of judges. The presentations will take place at the 2018 World Cancer Congress on October 3 in Kuala Lumpur, Malaysia, organized by the Union for International Cancer Control (UICC).
“UICC is delighted to continue partnering with Astellas on this integral initiative created to help bring good ideas in cancer care to life,” said Cary Adams, CEO of UICC.
“There is much that can be done to help improve cancer care in low-resource countries, and we are confident that through this global challenge we will uncover non-medical innovations that may help make a tangible difference in the lives of patients with cancer and their loved ones.”
Astellas will award $100,000 in funding, consisting of $50,000 for the Grand Prize and two $25,000 grants for the runners up. All three will receive a one-year “nights and weekends” membership to MATTER, a Chicago-based healthcare innovation community, which will help to bring their ideas to life.
The closing date for entries is July 25. More information about the awards and submission criteria can be found at: http://www.c3prize.com/
See terms and conditions at www.c3prize.com for full challenge rules and eligibility. Void where prohibited. No purchase necessary. No entries after July 25, 2018 at 11:59pm CST.
- WHO (2010). Cancer in developing countries: facing the challenge. Available from: http://www.who.int/dg/speeches/2010/iaea_forum_20100921/en/ (accessed July 2018)